See also this year's filing and all EDGAR filings for this company.
PDF Report 0001708331_2024_Virpax_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001708331, Virpax Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,628,345 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 7,694,024 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,572,181 |
| 9 | ResearchAndDevelopmentExpense | 5,117,608 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 500,281 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,628,345 |
| 1 | Liabilities | 7,694,024 |
| 2 | Expenses | 15,689,789 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,934,321 |
| 5 | NetIncome | -15,189,508 |
| 6 | ComprehensiveNetIncome | -15,189,508 |
| 7 | BaseVar | 16,756,220 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.27 |
| 9 | EconomicCapitalRatio | 1.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
